Vietnam To Take Steps To Curb Sharp Increase In Drug Costs
This article was originally published in PharmAsia News
The stability of Vietnam's drug prices has been shaken by a weaker Vietnamese currency coupled with an increase in the cost of imported drugs, the Drug Administration of Vietnam says. The Vietnam Pharmaceutical Companies Association said foreign drugs are expected to rise by as much as 10 percent because of the weaker dong against the U.S. dollar. The head of the Drugs Control Department of Vietnam said local drug companies invested less in their companies last year because of the decline in the economy, but said the DCD would take steps to discourage price increases by inviting more bids and licensing more makers. (Click here for more
You may also be interested in...
FDA's COVID-19 Naughty List Now Includes Marketers Of Copper Germ Stoppers, ‘24-Hour’ Hand Sanitizer
Warning letters issued by the US FDA on 28 May target two companies using COVID-19 and other disease-prevention claims to market purported germ-killing products, including a rub touted as 24-hour protection and a line of copper rollers and other implements to disinfect hands and personal items.
Industry-funded survey by Charles River Associates explores diverse perceptions about pricing for high-cost cell treatments – including curative cell and gene therapy – among various stakeholder groups.
Focused on precision medicine for renal disease, Chinook gets Aduro’s Nasdaq listing and starting capital of $200m. During a wave of modest-sized M&A deals, Tetra finds buyer, Tetraphase gets competing bids.